ArticleBioresources and bioprocessing2025
Traditional processing unlocks anti-atherogenic potential of perilla fruit via PPAR-γ activation by luteolin.
Article in Bioresources and bioprocessing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The accumulation of foam cells, lipid-laden macrophages in atherosclerotic plaques, is a hallmark of cardiovascular disease progression. These cells contribute to chronic inflammation and plaque instability, underscoring the need for novel therapeutic strategies. Peroxisome proliferator-activated receptor gamma (PPAR-γ) is a nuclear receptor pivotal to lipid metabolism and inflammation control. Traditional Chinese Medicine (TCM) processing techniques, such as stir-frying, are believed to enhance herb efficacy, yet the molecular basis remains insufficiently understood. Here, we demonstrate that stir-fried Perilla fruit significantly increase luteolin content-a flavonoid compound capable of binding PPAR-γ at key residues (SER289, HIS323, PHE360, TYR473) as validated by molecular docking and dynamics simulation. In ox-LDL-induced RAW264.7 macrophages, luteolin promoted cholesterol efflux, reduced lipid accumulation, and upregulated PPAR-γ pathway proteins, effects that were abolished by the antagonist GW9662. These results provide mechanistic insight into the enhanced efficacy of stir-fried Perilla and highlight luteolin as a promising natural compound for atherosclerosis prevention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.